Search results
Wave Life Sciences (WVE) Up 26% on Collaboration With GSK
Zacks via Yahoo Finance· 1 year agoWave Lifesciences (WVE) signs a four-year research collaboration with GSK to advance discovery and...
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
Zacks via Yahoo Finance· 1 month agoStoke Therapeutics, Inc. STOK reported encouraging new data from two phase I/IIa studies and two...
Why This PepGen Analyst Is Bullish On The Biotech Stock
Benzinga via Yahoo Finance· 1 year agoHC Wainwright initiated coverage of PepGen Inc (NASDAQ: PEPG) with a Buy rating and $26 price...
Biogen (BIIB) Inks Licensing Deal for Implantable Medical Device
Zacks via Yahoo Finance· 1 year agoBiogen (BIIB) signs a license and collaboration agreement with Alcyone Therapeutics to develop the...
Stoke shares surge on updated results for Dravet drug
BioPharma Dive via Yahoo Finance· 1 month agoThe biotech is trying to develop a Spinraza-like drug for the condition, a form of genetic epilepsy....
Why Ultragenyx Pharmaceutical Stock Is Cratering Today
Motley Fool· 2 years agoWhat happened Shares of the rare disease specialist Ultragenyx Pharmaceutical (NASDAQ: RARE) are...
Ultragenyx (RARE) Posts Update From AS Study of GTX-102
Zacks via Yahoo Finance· 4 months agoUltragenyx (RARE) completes enrollment in the phase I/II study of GTX-102 for the treatment of...
Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Reuters via Yahoo News· 10 months ago(Reuters) - Eisai Co Ltd and Biogen Inc's Leqembi emerged as the first Alzheimer's treatment to win...
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Benzinga via Yahoo Finance· 1 year agoBiogen Inc (NASDAQ: BIIB) posted Q1 FY23 sales of $2.46 billion, beating the consensus of $2.34...
Amylyx Pharmaceuticals Inc (AMLX) Reports Robust Revenue Growth and Net Income for Full Year 2023
GuruFocus.com via Yahoo Finance· 2 months agoNet Product Revenue: Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) reported a significant increase in net...